Forma Therapeutics Holdings (FMTX) Peer Comparison

$20.01

$0.00 (0.00%)

As on 21-Oct-2022 09:30EDT

Market cap

$1,008 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Edit

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Market cap ($ Mln)	1,008	814	2,941
Revenue ($ Mln)	--	176	4,649
Net Profit ($ Mln)	-190.16	-701.99	-13.00
Net Margin (%)	-21,707.19	-400.00	-0.28
RoE (%)	-41.66	--	-0.86
Price to Earnings	--	--	--
Price-To-Book	2.31	9.54	1.95

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Operating Revenue	0.00	175.50	4,649.00
Cost of Revenue	0.00	55.42	3,767.00
Gross Profit	--	173.75	858.00
Operating Expenses	191.13	844.87	883.00
Operating Profit (EBIT)	-191.13	-803.55	-1.00
Other Income	0.88	0.00	3.00
Profit before Tax	-190.13	-650.53	-26.00
Provision for Tax	0.03	10.01	-13.00
Profit after Tax (Net Income)	-190.16	-701.99	-13.00
Minority Interest	0.00	0.00	0.00
Consolidated Profit	-190.16	-1,190.49	-13.00

Liabilities ($ Mln)

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Shareholder's Funds	414.49	0.00	1,505.00
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	27.21	0.00	1,138.00
Current Liabilities	33.46	261.58	733.00
Total Liabilities	561.06	2,067.63	3,410.00

Assets ($ Mln)

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Non-Current Assets	48.72	0.00	2,020.00
Current Assets	426.45	1,000.73	1,378.00
Total Assets	561.06	2,067.63	3,410.00
Total Debt*	32.55	0.00	1,049.00
Net Current Assets	392.98	0.00	645.00

Cashflow ($ Mln)

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Cash From Operating Activities	-149.79	-1,211.97	102.00
Cash Flow from Investing Activities	-55.38	-18.12	-140.00
Cash from Financing Activities	-0.46	1,332.75	-66.00
Net Cash Inflow / Outflow	-205.62	--	-104.00

Ratios

Profitability Ratios

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
ROCE (%)	-29.33	-67.60	-2.09
ROE (%)	-41.66	-96.74	-0.86
ROA (%)	-32.98	-42.54	-0.31
EBIT Margin (%)	--	-549.20	0.04
Net Margin (%)	-21,707.19	-400.00	-0.28
Cash Profit Margin (%)	--	--	0.00

Growth Ratios

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Revenue Growth (%)	--	-30.37	2.42
EBIT Growth (%)	-31.08	16.03	104.76
Net Profit Growth (%)	-40.08	38.86	84.88
EPS Growth (%)	-10.92	-0.06	86.14
Book Value Growth (%)	-29.95	--	-1.95

Valuation Ratios

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Price / Earnings	-3.86	-0.90	-50.66
Price / Book Value	1.34	0.99	1.81
Dividend Yield (%)	--	--	--
EV/EBITDA	-1.37	-0.28	20.22
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Debt to Equity	0.00	0.85	0.65
Short term debt to equity ratio	0.01	0.02	0.04
Current Ratio	12.74	3.83	1.88
Quick Ratio	12.74	3.82	1.08
Interest Coverage	-213.11	-26.58	0.07

Operating Efficiency Ratios

	Forma Therapeutics Holdings (FMTX)	Zealand Pharma A/S - ADR	Covetrus (CVET)
Debtors to sales (%)	--	47.14	14.11
Asset Turnover	0.00	0.11	1.13
Receivable days	--	76.83	45.07
Inventory Days	--	252.29	54.68
Payable days	--	190.39	41.62
Cash Conversion Cycle	--	138.73	58.14

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly